MedTrace Logo

Effect of Kinesiotaping on Ankle Stability

NCT02115217 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-01-31

No results posted yet for this study

Summary

Ankles sprains are the most popular injuries in basketball players. They are traumatic injuries, which happen most of the time in specific situations, like landing on another player's foot, or during changes of direction.

Neuromuscular exercises are very important to improve ankle stability and reduce risks of sprains. However various external support such as ankles braces and rigid tape, are also used in order to prevent injury.

The kinesiotape (KT) is a new but broadly used method in the world of athletes. Created by KenzoKase, in 1980, this kind of tape has a tremendous success with athletes and is today commonly used during practices and/or competitions. The main property of this tape is its elasticity, which is supposed to improve proprioception and, thus ankle stability, but these aspects have not been investigated yet.

Conditions

  • Sprain and Strain of Ankle

Interventions

DEVICE

Leukotape K

All interventions will be performed by a qualified physiotherapist in a standardized manner. Tape will be extended to the recommended length (120%) and applied along the outer side of the leg, along the path of the peroneal muscle. Starting in the middle of the foot arch, the tape ends 1 cm below tibial head.

DEVICE

Sham kinesiotape

KT put with no effects

Sponsors & Collaborators

  • University of Lausanne

    collaborator OTHER

  • Clinique Romande de Readaptation

    lead NETWORK

Principal Investigators

  • Yan Eggel, MD · Clinique Romande de Readaptation

  • Lia Volpe, Student · Institut des Sciences du Sport de l'Université de Lausanne

  • Olivier Dériaz, Md, PhD · Institut de Recherche en Readaptation

  • Jérôme Barral, PhD · Institut des Sciences du Sport de l'Université de Lausanne

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
15 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2014-11-30
Completion
2015-06-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02115217 on ClinicalTrials.gov